Clinical Trials Directory

Trials / Unknown

UnknownNCT04467177

Analgesic Effect of Oral Glucose in Neonates

Efficacy of Oral Glucose in Pain Alleviation Among Healthy Term Neonates Undergoing Circumcision

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Makassed General Hospital · Academic / Other
Sex
Male
Age
1 Day – 28 Days
Healthy volunteers
Not accepted

Summary

Background: Male circumcision is one of the oldest and most common operations performed all over the world. It can be performed at different ages, using different surgical techniques, for different religious, cultural and medical reasons. It was thought that the newborn baby does not experience pain because of incompletely developed nervous system. However, it has been shown that neurological system known to be associated with pain transmission and modulation, is intact and functional. OBJECTIVE: Our objective is to determine if a 30% glucose solution would reduce pain after circumcision compared with normal saline. STUDY DESIGN: This is a randomized placebo-controlled double-blinded clinical trial. POPULATION: We will include full term neonates, who will be recruited from the inpatient nursery at Makassed General Hospital over a 1-year period. OUTCOME MEASURE: The primary outcome is to assess efficacy of 30% glucose on pain measured using the Neonatal Infant Pain Score. Secondary outcome is to assess effect of 30% glucose oh physiologic parameters

Conditions

Interventions

TypeNameDescription
OTHER30% glucoseMale neonates will receive 2 ml of 30% glucose two minutes prior to circumcision
OTHERPlaceboMale neonates will receive 2 ml of sterile water two minutes prior to circumcision

Timeline

Start date
2020-07-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-07-10
Last updated
2020-07-10

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT04467177. Inclusion in this directory is not an endorsement.